Author

Qing‐Peng Kong

Kunming Institute of ZoologyORCID 0000-0002-6046-4494Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Assay:metabolomics· 2 Approach:statistical model· 2 Research Focus:benchmarking· 1 Research Focus:drug response / drug discovery· 1 Assay:GWAS summary statistics· 1 Organism:human· 1 Approach:machine learning (classical)· 1

Frequent Co-Authors

Feifei HaniD· 2 shared Gong‐Hua LiiD· 2 shared Wenzhong XiaoiD· 2 shared Chia-Jung ChangiD· 1 shared Efthymios KalafatisiD· 1 shared Jing‐Fei HuangiD· 1 shared Peng LiiD· 1 shared Rong‐Hua LuoiD· 1 shared

Activity by Year

2023-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersSystems Biology

Feifei HanORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Systems BiologyInternational Journal of Molecular SciencesPeer-reviewedJun 25, 2025

Systems Modeling Reveals Shared Metabolic Dysregulation and Novel Therapeutic Treatments in ME/CFS and Long COVID

Gong‐Hua Li, Feifei Han, Efthymios Kalafatis…·Wenzhong Xiao

This study identifies shared metabolic dysregulation in ME/CFS and Long COVID using genome-wide metabolic modeling and suggests potential therapeutic interventions.

5 citations

humanmetabolomics

𝕏 PostBluesky

Systems BiologybioRxivPreprintJul 24, 2023

Predictive Systems Biology Modeling: Unraveling Host Metabolic Disruptions and Potential Drug Targets in Acute Viral Infections

Gong‐Hua Li, Feifei Han, Rong‐Hua Luo…·Wenzhong Xiao

This paper introduces vhMM, a method to model host metabolic disruptions in viral infections and identify drug targets, finding effective compounds and linking cinnamon use to reduced SARS-CoV-2 infection rates.

DOI 10.1101/2023.07.24.550423

virusmetabolomics

𝕏 PostBluesky